ALKIRE JOSEPH A

Officer · KTB

As of 2026-09-16, ALKIRE JOSEPH A has 10 Form 4 transactions on record across 1 company — 8 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $3.7MIndirect: $0$3.7Mas of 2026-09-16
  • Direct $3.7M
  • Indirect $0
KTBdirect54,844 sh$3.7M

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

KTB · 10 trades
2026-04-01: Withheld for tax, 1,298 sh ($90K)2026-04-01: Withheld for tax, 1,193 sh ($83K)2026-04-01: Award / grant, 9,821 sh ($0)2026-03-05: Withheld for tax, 17,294 sh ($1.4M)2026-02-23: Award / grant, 39,426 sh ($0)2025-11-10: Sale, 3,000 sh ($217K)2025-09-22: Withheld for tax, 3,204 sh ($257K)2025-09-22: Withheld for tax, 852 sh ($68K)2025-04-01: Withheld for tax, 1,218 sh ($78K)2025-04-01: Award / grant, 7,991 sh ($0)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
2025-11-10KTBSale3,000 @ $72.35$217K−10.7% of holding25,126Form 4
9 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-04-01KTBWithheld for tax1,29856,037Form 4
2026-04-01KTBWithheld for tax1,19354,844Form 4
2026-04-01KTBAward / grant9,82157,335Form 4
2026-03-05KTBWithheld for tax17,29447,389Form 4
2026-02-23KTBAward / grant39,42664,684Form 4
2025-09-22KTBWithheld for tax3,20428,126Form 4
2025-09-22KTBWithheld for tax85231,330Form 4
2025-04-01KTBWithheld for tax1,21823,829Form 4
2025-04-01KTBAward / grant7,99131,820Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.